The Swedish government and Volvo have reached an agreement over the food and pharmaceutical conglomerate Procordia. The Swedish car manufacturer had planned to merge with Procordia in a takeover bid, but the government will continue with its plan to privatize the minority stake that it holds. However, Volvo will hold the largest stake in Procordia, increasing its 42.7% to 45%. The government holds 40%.
Procordia's pretax profit for 1991 was 3.3 billion Swedish kroner ($554.4 million), up 200% on the previous year. This was attributed to the health care unit, Kabi Pharmacia, making a strong recovery from a restructuring program. Operating profit at Kabi Pharmacia grew 41% to 2.1 billion kroner in 1991, and sales were 9.5 billion kroner, up 12%. The biotech operation, Pharmacia Biosystems, made operating profit of 272 million kroner, having made a loss of 95 million kroner in the previous year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze